Related Experiment Videos
[Interaction between thrombocytes and blood vessel wall--significance for acute ischemic coronary syndromes]
S D Kristensen1, S E Husted, H K Nielsen
1Kardiologisk afdeling B, Skejby Sygehus, Arhus.
Insights
Platelets play a crucial role in forming intracoronary thrombus, a key factor in acute ischemic coronary syndromes. Therapies targeting platelet activity, like aspirin, can reduce heart attack incidence and mortality.
Area of Science:
- Cardiovascular Medicine
- Hematology
- Pathophysiology
Context:
- Intracoronary thrombus formation underlies acute ischemic coronary syndromes (ACS).
- Atherosclerotic plaque rupture initiates thrombosis, but platelet reactivity is also critical.
- ACS includes unstable angina pectoris (UAP), myocardial infarction (MI), and sudden cardiac death.
Purpose:
- To highlight the significant role of platelets in intracoronary thrombus formation.
- To present evidence supporting platelet involvement in the pathogenesis of ACS.
- To underscore the therapeutic potential of antiplatelet agents.
Summary:
- Platelet aggregability increases in the morning, coinciding with higher MI and sudden cardiac death rates.
- Increased mean platelet volume and thromboxane A2 synthesis are observed during acute MI and UAP.
- High platelet count, increased ADP-induced aggregation, and elevated mean platelet volume are risk factors for MI and mortality.
Impact:
- Demonstrates that platelet inhibition with acetylsalicylic acid reduces MI incidence and mortality.
- Provides evidence for the efficacy of antiplatelet therapy in various ACS and post-MI patients.
- Supports the clinical importance of monitoring platelet function and volume in cardiovascular risk assessment.
Abstract:
Intracoronary thrombus formation is the essential pathogenic substrate for the development of the acute ischaemic coronary syndromes (unstable angina pectoris (UAP), acute myocardial infarction (MI) and sudden cardiac death). Rupture of an atherosclerotic plaque has been shown to be of major importance for initiation of the thrombogenic process, but the reactivity of the circulating platelets and their interaction with the coronary vessel wall are also important for the formation and propagation of the intracoronary thrombus. The evidence favouring the role of platelets is: 1) the aggregability of platelets is increased in the morning where the incidence of MI and sudden cardiac death has been shown to be high, 2) shortened bleeding time and increased mean platelet volume in the acute phase of MI, 3) the synthesis of proaggregatory thromboxane A2 is increased in the acute phase of MI and in UAP, 4) a high platelet count and an increased ADP-induced platelet aggregation predispose to MI and death in healthy males, 5) high mean platelet volume and increased spontaneous platelet aggregation are risk factors for MI and death in patients with a recent MI, 6) the platelet inhibitor, acetylsalicylic acid, has been shown to reduce the incidence of MI and mortality in patients with silent myocardial ischaemia, stable and unstable angina pectoris and in patients with MI.